DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Tata Chemicals Limited — Press Release

NSE 1 hr ago·27 Jul 2026, 1:00 pm

Tata Chemicals

Tata Chemicals Limited has released its financial results for the quarter ended June 30, 2026. The company has provided both unaudited consolidated and audited standalone financial results. This update is important for investors as it provides insight into the company's financial performance over the last quarter. Investors can use this information to assess the company's progress and make informed decisions. Investors should watch for further analysis and updates from the company, as well as any potential impact on the stock price of TATACHEM.